AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessment of Complication Risk Factors in a French National Cohort of Asplenic Patients

Recruitingn/aAges 18 Years - anyAllPoitiers University Hospital
💬

In plain words

What the trial is, and whether it could suit you

Spleen could have been surgically removed for trauma, cancer, auto-immune disease, or to perform a diagnosis. Spleen could be non-functional due to radiotherapy or splenic artery embolism. These patients are at risks of infectious diseases due to encapsulated bacteria, cancer, and thromboembolism disease. The purpose of this study is to assess complications occurring in French patients without spleen and to implement new diagnostic tools for follow-up.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * ≥18 year-old * With asplenia due to splenectomy, splenic artery embolization or radiotherapy Exclusion Criteria: * Genetic asplenia including sick cell disease
💊

What it tests

  • Not listed
📍

Where

12 sites
C.H. d'Angoulême
Angoulême, France
C.H. Victor Dupouy
Argenteuil, France
C.H. de Béthune
Béthune, France
Hôpitaux de Chartres
Chartres, France
C.H.U. de Lille
Lille, France
C.H.U. de Montpellier
Montpellier, France
Hôtel-Dieu - CHU de Nantes
Nantes, France
C.H.U. de Poitiers
Poitiers, France

…and 4 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy